Scientists discover two drugs that provide effective SARS-CoV-2 suppression

COVID-19 continues to claim lives across the world and is infecting millions more. Although several vaccines have recently become available, making significant strides towards preventing COVID-19, what about the treatment of those who already have the infection?

Vaccines aren't 100% effective, highlighting the need--now more than ever--for effective antiviral therapeutics. Moreover, some people can't receive vaccines due to health issues, and new variants of SARS-CoV-2, the virus that causes COVID-19, that can penetrate vaccine-conferred immunity, are being reported, indicating that we need to think beyond prevention.

Given this need, a team of researchers based in Japan, the US, and the UK launched a project to develop effective therapeutics. This team included several researchers based at Tokyo University of Science: Visiting Professor Koichi Watashi, Dr. Hirofumi Ohashi, Professor Shin Aoki, Professor Kouji Kuramochi, and Assistant Professor Tomohiro Tanaka. Their goal was clear and simple: finding a cure for COVID-19.

To achieve this goal, the researchers first established an experimental system for screening drugs that may help to control infections. This system used a type of cells called VeroE6/TMPRSS2 cells, which were manipulated to efficiently be infected with and produce SARS-CoV-2.

To determine whether a drug of interest could help combat infection by SARS-CoV-2, we simply had to expose VeroE6/TMPRSS2 cells to both the drug and SARS-CoV-2 and then observe whether the drug's presence served to hinder the virus's efforts to infect cells."

Koichi Watashi,Visiting Professor, Tokyo University of Science

The researchers used this experimental system to screen a panel of drugs that are already approved for clinical use, including drugs like remdesivir and chloroquine that have already being approved or are being trialed as treatments for COVID-19.

In an exciting outcome, the researchers found two drugs that provided effective SARS-CoV-2 suppression: cepharanthine, which is used to treat inflammation, and nelfinavir, which is approved for the treatment of HIV infection.

Cepharanthine inhibited the entry of the virus into cells by preventing the virus from binding to a protein on the cell membrane, which it uses as a gateway. In contrast, nelfinavir worked to prevent the virus from replicating inside the cell by inhibiting a protein that the virus relies on for replication.

Given that these drugs have distinct antiviral mechanisms, using both of them together could be especially effective for patients, with computational models predicting that combined cepharanthine/nelfinavir therapy can hasten the clearance of SARS-CoV-2 from a patient's lungs by as few as 4.9 days.

So, does this mean we will be seeing these new drugs in COVID-19 treatment centers? Of course, the drug duo isn't ready to be rolled out into healthcare systems just yet. These findings justify further research into the clinical potential of cepharanthine/nelfinavir therapy, and only following this can we say for sure that it is useful and helpful.

Nevertheless, given the ongoing nature of the COVID-19 pandemic and the ever-increasing death toll, the development of cepharanthine/nelfinavir therapy may provide clinicians and patients with a much-needed new treatment option.

Source:
Journal reference:

Ohashi, H., et al. (2021) Potential anti-COVID-19 agents, cepharanthine and nelfinavir, and their usage for combination treatment. iScience. doi.org/10.1016/j.isci.2021.102367.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Tokyo University of Science. (2022, December 19). Scientists discover two drugs that provide effective SARS-CoV-2 suppression. AZoLifeSciences. Retrieved on April 24, 2024 from https://www.azolifesciences.com/news/20210604/Scientists-discover-two-drugs-that-provide-effective-SARS-CoV-2-suppression.aspx.

  • MLA

    Tokyo University of Science. "Scientists discover two drugs that provide effective SARS-CoV-2 suppression". AZoLifeSciences. 24 April 2024. <https://www.azolifesciences.com/news/20210604/Scientists-discover-two-drugs-that-provide-effective-SARS-CoV-2-suppression.aspx>.

  • Chicago

    Tokyo University of Science. "Scientists discover two drugs that provide effective SARS-CoV-2 suppression". AZoLifeSciences. https://www.azolifesciences.com/news/20210604/Scientists-discover-two-drugs-that-provide-effective-SARS-CoV-2-suppression.aspx. (accessed April 24, 2024).

  • Harvard

    Tokyo University of Science. 2022. Scientists discover two drugs that provide effective SARS-CoV-2 suppression. AZoLifeSciences, viewed 24 April 2024, https://www.azolifesciences.com/news/20210604/Scientists-discover-two-drugs-that-provide-effective-SARS-CoV-2-suppression.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of AZoLifeSciences.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Researchers enhance antibacterial activity of hydrogen peroxide using copper-containing polymers